Revolutionizing ovarian cancer treatment with adaptive PARP inhibitor therapy
Ovarian cancer, often diagnosed at an advanced stage, presents significant treatment challenges because patients tend to develop resistance to conventional therapies quickly. Despite aggressive treatment, recurrence rates ...
Jun 26, 2024
0
0